OmniAb (OABI) Retained Earnings (2021 - 2026)
OmniAb (OABI) reported Retained Earnings of -$2000.0 for Q1 2026, down 125.0% year-over-year from $8000.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$166.2 million in Q4 2025.
OmniAb (OABI) Retained Earnings (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Retained Earnings data on file, last reported at -$2000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$2000.0, down 125.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2000.0 (down 125.0% YoY), and the FY2025 annual result was -$166.2 million, down 615577.78% from the prior year.
- Retained Earnings climbed to -$2000.0 in Q1 2026 per OABI's latest filing, from -$166.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $5.2 million in Q1 2023 and troughed at -$166.2 million in Q4 2025.
- A 5-year average of -$36.5 million and a median of -$13.9 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings soared 141.67% in 2023, then sank 615577.78% in 2025.
- A 5-year view of Retained Earnings shows it stood at $9000.0 in 2022, then sank by 437511.11% to -$39.4 million in 2023, then jumped by 100.07% to $27000.0 in 2024, then slumped by 615577.78% to -$166.2 million in 2025, then soared by 100.0% to -$2000.0 in 2026.
- Business Quant data shows OABI's Retained Earnings at -$2000.0 in Q1 2026, -$166.2 million in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | -166.18 Mn |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -135.48 Mn |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | -88.33 Mn |
| Jun 30, 2024 | -71.96 Mn |
| Mar 31, 2024 | -58.33 Mn |
| Dec 31, 2023 | -39.37 Mn |
| Sep 30, 2023 | -25.31 Mn |
| Jun 30, 2023 | -49,000.00 |
| Mar 31, 2023 | 5.15 Mn |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | -13.87 Mn |
| Jun 30, 2022 | -14.34 Mn |
| Mar 31, 2022 | -12.36 Mn |
| Sep 30, 2021 | -6.90 Mn |
| Jun 30, 2021 | -9,971.00 |